These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11863110)

  • 1. Merits, Challenges, and Limitations of Randomized Trials on Colorectal Cancer Screening Effectiveness.
    Brenner H; Cross AJ
    Gastroenterology; 2021 Mar; 160(4):1009-1011. PubMed ID: 33359088
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal Cancer Screening: Randomized Trials Are Essential to Support Recommendations.
    Bretthauer M; Schoen RE; Cross AJ; Pinsky PF
    Ann Intern Med; 2022 Jan; 175(1):129-130. PubMed ID: 34748373
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.
    Rosman AS; Korsten MA
    J Gen Intern Med; 2010 Nov; 25(11):1211-21. PubMed ID: 20499198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
    Yang H; Ge Z; Dai J; Li X; Gao Y
    Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal occult blood test for colorectal cancer screening.
    Strul H; Arber N
    Ann Oncol; 2002 Jan; 13(1):51-6. PubMed ID: 11863111
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for colorectal cancer--which strategy is the best?
    Church TR
    J Natl Cancer Inst; 2011 Sep; 103(17):1282-3. PubMed ID: 21852265
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecal occult blood testing as a screening procedure for colorectal cancer.
    Lowenfels AB
    Ann Oncol; 2002 Jan; 13(1):40-3. PubMed ID: 11863108
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendation to include colorectal cancer screening in public health policy. The European Group for Colorectal Cancer Screening.
    J Med Screen; 1999; 6(2):80-1. PubMed ID: 10444725
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemoccult should no longer be used for the screening of colorectal cancer.
    Bleiberg H
    Ann Oncol; 2002 Jan; 13(1):44-6. PubMed ID: 11863109
    [No Abstract]   [Full Text] [Related]  

  • 10. Is colorectal cancer screening by fecal occult blood feasible?
    Crespi M; Lisi D
    Ann Oncol; 2002 Jan; 13(1):47-50. PubMed ID: 11863110
    [No Abstract]   [Full Text] [Related]  

  • 11. Fecal occult blood testing for colorectal cancer. Can we afford not to do this?
    Bond JH
    Gastroenterol Clin North Am; 1997 Mar; 26(1):57-70. PubMed ID: 9119440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.
    Greenwald B
    Gastroenterol Nurs; 2005; 28(2):90-6. PubMed ID: 15832108
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.